FMP
NASDAQ
16.02 USD
-0.165 (-1.03%)
Dr. Ying Du Ph.D.
Healthcare
Biotechnology
https://www.zailaboratory.com
NASDAQ
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. It also develops Odronextamab to treat follicular lymphoma, diffuse large B-cell lymphoma, and other B-celllymphomas; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in T...
0001704292
US98887Q1040
98887Q104
Jinchuang Plaza
86 21 6163 2588
CN
2,175
Sep 20, 2017
0001704292
NASDAQ
Biotechnology
Healthcare
98887Q104
US98887Q1040
CN
16.02
1.13
665.82k
1.58B
-
15.69-40.42
47.29
-
-
-
-
-4.58
-
https://www.zailaboratory.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.